Is semaglutide approved for weight loss?

You have seen semaglutide advertised for weight loss and want to know whether that use is actually approved. The answer comes from a federal health source, and it is worth reading closely, because the exact wording matters.

Yes, according to NIDDK (NIH), semaglutide is one of six drugs the FDA has approved for long-term use. It sits on that list as semaglutide (Wegovy), alongside orlistat, phentermine-topiramate, naltrexone-bupropion, liraglutide and tirzepatide.

What that approval covers

Read the sentence again. The approval is attached to named products. Semaglutide appears there as Wegovy, next to five other drugs. Cause and effect is simple here: the approval describes a specific product, so anything offered under a different name or form is not described by that sentence.

NIDDK (NIH) also says the FDA has approved four weight management medications for children ages 12 and older, and semaglutide (Wegovy) is on that shorter list too.

More on obesity and tirzepatide

For background on the condition these drugs are aimed at, start with the MedlinePlus overview of obesity, the Cleveland Clinic page on weight control and obesity and the NHS guidance on overweight and obesity in adults. If you are comparing semaglutide with its closest alternative, the MedlinePlus drug information on tirzepatide injection is a clear place to read the other side.

Naming the exact product

Ask which product exactly is being prescribed, by name. If the answer is Wegovy, it matches the approval above. If it is anything else, ask the provider to point you to the source that covers it before you pay.